components_HeaderAdBanner_2

components_HeaderAdBanner_3
components_StockPageHeaderMobile__0
components_StockPageHeaderMobile__1

Vifor Pharma

VIFN.SW
CH0364749348
A2DRZ4

components_StockPageHeaderMobile__3

166,15 CHF
components_StockPageHeader__1
+0 CHF
components_StockPageHeader__2
+0 %
P

components_charts_RevenueChart_0

components_charts_RevenueChart_13

Vifor Pharma components_charts_RevenueChart_15

components_charts_RevenueChart_14Vifor Pharma components_charts_RevenueChart_8Vifor Pharma components_charts_RevenueChart_10Vifor Pharma components_charts_RevenueChart_9
2026e3,00 number_format_mrd CHF948,40 number_format_mio CHF692,86 number_format_mio CHF
2025e2,71 number_format_mrd CHF801,47 number_format_mio CHF583,34 number_format_mio CHF
2024e2,42 number_format_mrd CHF543,66 number_format_mio CHF326,31 number_format_mio CHF
2023e2,12 number_format_mrd CHF468,18 number_format_mio CHF280,64 number_format_mio CHF
2022e1,90 number_format_mrd CHF408,00 number_format_mio CHF240,27 number_format_mio CHF
20211,75 number_format_mrd CHF351,80 number_format_mio CHF144,40 number_format_mio CHF
20201,71 number_format_mrd CHF260,30 number_format_mio CHF359,60 number_format_mio CHF
20191,88 number_format_mrd CHF325,00 number_format_mio CHF159,10 number_format_mio CHF
20181,58 number_format_mrd CHF227,40 number_format_mio CHF152,40 number_format_mio CHF
20171,29 number_format_mrd CHF134,30 number_format_mio CHF1,15 number_format_mrd CHF
20161,17 number_format_mrd CHF236,40 number_format_mio CHF237,10 number_format_mio CHF
20153,79 number_format_mrd CHF451,84 number_format_mio CHF301,06 number_format_mio CHF
20143,42 number_format_mrd CHF370,19 number_format_mio CHF284,45 number_format_mio CHF
20133,36 number_format_mrd CHF390,40 number_format_mio CHF296,20 number_format_mio CHF
20123,29 number_format_mrd CHF345,90 number_format_mio CHF253,50 number_format_mio CHF
20113,19 number_format_mrd CHF326,90 number_format_mio CHF223,10 number_format_mio CHF
20103,10 number_format_mrd CHF320,90 number_format_mio CHF230,40 number_format_mio CHF
20093,28 number_format_mrd CHF263,90 number_format_mio CHF210,20 number_format_mio CHF
20083,13 number_format_mrd CHF263,40 number_format_mio CHF188,40 number_format_mio CHF
20072,60 number_format_mrd CHF154,30 number_format_mio CHF134,10 number_format_mio CHF
20062,21 number_format_mrd CHF111,60 number_format_mio CHF103,40 number_format_mio CHF
20052,14 number_format_mrd CHF101,80 number_format_mio CHF79,90 number_format_mio CHF
20042,96 number_format_mrd CHF96,90 number_format_mio CHF77,40 number_format_mio CHF
20032,73 number_format_mrd CHF91,30 number_format_mio CHF66,60 number_format_mio CHF
20022,33 number_format_mrd CHF87,30 number_format_mio CHF59,00 number_format_mio CHF

Vifor Pharma components_StockTable__14

  • components_StockTable_20

  • components_StockTable_21

  • components_StockTable_17

  • components_StockTable_18

  • components_StockTable_19

components_StockTable__16
components_StockDataTable_BalanceSheet_49

components_PaywallOverlay_0

components_PaywallOverlay_1

components_charts_MarginsChart_0

components_charts_MarginsChart_19

Vifor Pharma components_charts_MarginsChart_21

Vifor Pharma components_charts_MarginsChart_15Vifor Pharma components_charts_MarginsChart_16Vifor Pharma components_charts_MarginsChart_17Vifor Pharma components_charts_MarginsChart_16
2026e61,70 %31,63 %23,11 %
2025e61,70 %29,56 %21,51 %
2024e61,70 %22,43 %13,46 %
2023e61,70 %22,08 %13,24 %
2022e61,70 %21,48 %12,65 %
202161,70 %20,05 %8,23 %
202058,89 %15,26 %21,08 %
201959,43 %17,31 %8,48 %
201859,06 %14,35 %9,62 %
201759,91 %10,40 %88,81 %
201661,81 %20,26 %20,32 %
201521,16 %11,92 %7,94 %
201417,54 %10,84 %8,33 %
201317,31 %11,62 %8,82 %
201217,05 %10,50 %7,70 %
201116,41 %10,26 %7,00 %
201017,41 %10,34 %7,42 %
200923,90 %8,05 %6,42 %
200825,33 %8,42 %6,02 %
200716,91 %5,94 %5,16 %
200619,14 %5,04 %4,67 %
200518,43 %4,75 %3,73 %
200419,19 %3,28 %2,62 %
200319,08 %3,35 %2,44 %
200219,82 %3,75 %2,53 %

components_charts_RevenuePerShareChart_0

components_charts_RevenuePerShareChart_16

Vifor Pharma components_charts_RevenuePerShareChart_18

components_charts_RevenuePerShareChart_17Vifor Pharma components_charts_RevenuePerShareChart_10Vifor Pharma components_charts_RevenuePerShareChart_12Vifor Pharma components_charts_RevenuePerShareChart_11
2026e46,21 CHF0 CHF10,68 CHF
2025e41,79 CHF0 CHF8,99 CHF
2024e37,35 CHF0 CHF5,03 CHF
2023e32,67 CHF0 CHF4,32 CHF
2022e29,26 CHF0 CHF3,70 CHF
202126,99 CHF5,41 CHF2,22 CHF
202026,23 CHF4,00 CHF5,53 CHF
201928,86 CHF5,00 CHF2,45 CHF
201824,37 CHF3,50 CHF2,34 CHF
201719,90 CHF2,07 CHF17,67 CHF
201617,99 CHF3,64 CHF3,66 CHF
201558,42 CHF6,96 CHF4,64 CHF
201452,65 CHF5,71 CHF4,38 CHF
201351,76 CHF6,02 CHF4,56 CHF
201250,76 CHF5,33 CHF3,91 CHF
201149,11 CHF5,04 CHF3,44 CHF
201047,69 CHF4,93 CHF3,54 CHF
200950,48 CHF4,07 CHF3,24 CHF
200848,28 CHF4,06 CHF2,91 CHF
200739,95 CHF2,37 CHF2,06 CHF
200634,02 CHF1,71 CHF1,59 CHF
200532,89 CHF1,56 CHF1,23 CHF
200445,50 CHF1,49 CHF1,19 CHF
200341,98 CHF1,40 CHF1,02 CHF
200235,82 CHF1,34 CHF0,91 CHF

pages_aktie_[isin]__4

pages_aktie_[isin]__5

pages_aktie_[isin]__7

components_charts_DividendChart_7

components_charts_DividendChart_10

Vifor Pharma components_charts_DividendChart_11

components_charts_DividendChart_12Vifor Pharma components_charts_DividendChart_8
2026e7,47 CHF
2025e6,28 CHF
2024e3,77 CHF
2023e2,82 CHF
2022e2,57 CHF
20212,00 CHF
20202,00 CHF
20192,00 CHF
20182,00 CHF
20172,00 CHF
20161,80 CHF
20151,50 CHF
20141,40 CHF
20131,10 CHF
20120,90 CHF
20110,80 CHF
20100,75 CHF
20090,70 CHF
20080,60 CHF
20070,50 CHF
20060,43 CHF
20050,39 CHF
20040,36 CHF
20030,33 CHF

components_PaywallOverlay_0

components_PaywallOverlay_1
pages_aktie_[isin]__2

Vifor Pharma components_EarningsSuprises__0

components_EarningsSuprises__1components_EarningsSuprises__2components_EarningsSuprises__3components_EarningsSuprises__4
30.6.20211,94 CHF1,92 CHF (−0,93 %)2021 Q2
31.12.20202,49 CHF4,49 CHF (80,04 %)2020 Q4
30.6.20202,54 CHF1,04 CHF (−59,05 %)2020 Q2
31.12.20191,98 CHF0,34 CHF (−82,82 %)2019 Q4
30.6.20192,29 CHF2,11 CHF (−7,86 %)2019 Q2
31.12.20181,15 CHF0,52 CHF (−54,68 %)2018 Q4
30.6.20181,32 CHF1,82 CHF (37,61 %)2018 Q2
31.12.20171,02 CHF0,67 CHF (−34,51 %)2017 Q4
31.12.20161,73 CHF1,31 CHF (−24,68 %)2016 Q4
30.6.20162,53 CHF2,45 CHF (−3,13 %)2016 Q2
1
2
3

components_ESGRating_6

components_ESGRating_7

components_PaywallOverlay_0

components_PaywallOverlay_1

pages_aktie_[isin]__9

components_OwnershipTable__4
components_OwnershipTable__0
components_OwnershipTable__1
components_OwnershipTable__2
components_OwnershipTable__3
98,39 % CSL Ltd63 849 04548 677 1839.8.2022
0,21 % The Vanguard Group, Inc.135 157731.10.2022
0,20 % Florida State Board of Administration131 48782 37330.9.2022
0,17 % California Public Employees' Retirement System112 479−8 01330.6.2021
0,15 % PGGM Vermogensbeheer B.V.98 69759 14131.12.2021
0,07 % California State Teachers Retirement System46 626−20 82430.6.2022
0,06 % Nordea Funds Oy37 454−68 72431.10.2022
0,05 % Deka Investment GmbH33 970−3 06130.6.2022
0,05 % State Street Global Advisors (UK) Ltd.33 051−7 21330.6.2022
0,04 % Valiant Bank AG23 60034030.9.2021
1
2
3
4
5
...
10

Vifor Pharma components_CompanyExecutives__0

Mr. Abbas Hussain57
Vifor Pharma Chief Executive Officer
components_CompanyExecutives__2 2,10 number_format_mio CHF
Mr. Jacques Theurillat62
Vifor Pharma Independent Chairman of the Board of Directors
components_CompanyExecutives__2 1,20 number_format_mio CHF
Dr. Romeo Cerutti59
Vifor Pharma Independent Vice Chairman of the Board
components_CompanyExecutives__2 326 000,00 CHF
Dr. Sue Mahony56
Vifor Pharma Independent Directors
components_CompanyExecutives__2 260 000,00 CHF
Prof. Dr. Michel Burnier67
Vifor Pharma Independent Directors
components_CompanyExecutives__2 231 000,00 CHF
1
2
3

pages_aktie_[isin]__1

What values and corporate philosophy does Vifor Pharma represent?

Vifor Pharma AG represents a set of core values and corporate philosophy that guides its operations. The company's values include a strong commitment to patients, healthcare providers, and employees. Vifor Pharma AG strives to make a positive impact on patients' lives through innovative healthcare solutions. The company's corporate philosophy centers around trust, integrity, and excellence. Vifor Pharma AG focuses on continuous improvement and delivering value to its stakeholders. With a patient-centric approach, Vifor Pharma AG aims to enhance patient outcomes and drive sustainable growth in the pharmaceutical industry.

In which countries and regions is Vifor Pharma primarily present?

Vifor Pharma AG is primarily present in various countries and regions worldwide. Its presence can be seen in Europe, North America, and certain parts of Asia. The company operates in diverse markets, including Switzerland, Germany, Austria, France, the United Kingdom, the United States, China, and Japan. With a global reach, Vifor Pharma AG has established itself as a leading pharmaceutical player in these regions, offering innovative healthcare solutions and improving patient outcomes.

What significant milestones has the company Vifor Pharma achieved?

Vifor Pharma AG, a renowned pharmaceutical company, has achieved several significant milestones throughout its existence. Notably, it successfully developed and launched a groundbreaking medication for the treatment of iron deficiency anemia (IDA) called Ferinject®. This innovative intravenous iron replacement therapy has transformed patient care worldwide. Vifor Pharma AG has also made strides in the field of nephrology, advancing the treatment of chronic kidney disease (CKD) and associated complications. With a strong focus on research and development, Vifor Pharma AG continues to seek out new therapeutic options and strategic partnerships to further enhance patient outcomes and improve global healthcare.

What is the history and background of the company Vifor Pharma?

Vifor Pharma AG, a leading global pharmaceutical company, has a rich history and background. Established in 1872 and headquartered in Switzerland, Vifor Pharma focuses on innovative treatments for patients suffering from iron deficiency, nephrology, and cardio-renal disorders. The company has played a pivotal role in healthcare advancements, leveraging its expertise to develop high-quality and effective pharmaceutical products. Vifor Pharma operates globally, collaborating with healthcare professionals to improve patients' well-being. Committed to research, development, and sustainable growth, Vifor Pharma aims to enhance the lives of individuals worldwide through its innovative solutions in the medical field.

Who are the main competitors of Vifor Pharma in the market?

The main competitors of Vifor Pharma AG in the market include companies like Novartis, Roche, Sanofi, and AstraZeneca. These companies operate in similar therapeutic areas and engage in the development and commercialization of pharmaceutical products. Vifor Pharma AG competes with these companies through its innovative and high-quality offerings, strategic partnerships, and strong market presence. By continuously adapting and expanding its product portfolio, Vifor Pharma AG aims to maintain its competitive position within the pharmaceutical industry.

In which industries is Vifor Pharma primarily active?

Vifor Pharma AG is primarily active in the pharmaceutical industry.

What is the business model of Vifor Pharma?

The business model of Vifor Pharma AG focuses on the development, production, and commercialization of pharmaceutical products. As a global healthcare company, Vifor Pharma AG specializes in the field of iron deficiency, nephrology, and cardio-renal therapies. They aim to improve the quality of life for patients suffering from various medical conditions, including chronic kidney disease, iron deficiency anemia, and renal diseases. Vifor Pharma AG collaborates with healthcare professionals and organizations worldwide to bring innovative and effective treatments to market. By leveraging their expertise and research capabilities, Vifor Pharma AG continues to drive advancements in the field of pharmaceuticals and improve patient outcomes.

pages_aktie_[isin]__11

pages_aktie_[isin]__12

pages_aktie_[isin]__14

pages_aktie_[isin]__15

pages_aktie_[isin]__17

pages_aktie_[isin]__18

pages_aktie_[isin]__20

pages_aktie_[isin]__21

pages_aktie_[isin]__23

pages_aktie_[isin]__24

pages_aktie_[isin]__26

pages_aktie_[isin]__27

pages_aktie_[isin]__29

pages_aktie_[isin]__30

pages_aktie_[isin]__32

pages_aktie_[isin]__33

pages_aktie_[isin]__35

pages_aktie_[isin]__36

pages_aktie_[isin]__37

pages_aktie_[isin]__38

pages_aktie_[isin]__39

pages_aktie_[isin]__40

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Vifor Pharma kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

pages_aktie_[isin]__10

components_SimilarSitesList_0

components_GenericText_0

components_GenericText_1

components_GenericText_2

components_GenericText_3

components_GenericText_4

components_GenericText_5

components_GenericText_6

components_GenericText_7

components_GenericText_8

components_GenericText_9

components_GenericText_10

components_GenericText_11

components_GenericText_12

components_GenericText_13

components_GenericText_14

components_GenericText_15

components_GenericText_16

components_GenericText_17

components_GenericText_18

components_GenericText_19

components_GenericText_20

components_GenericText_21

components_GenericText_22

components_GenericText_23

components_GenericText_24

components_GenericText_25

components_GenericText_26

components_GenericText_27

components_GenericText_28

components_GenericText_29

components_GenericText_30

components_GenericText_31

components_GenericText_32

components_GenericText_33

components_GenericText_34

components_GenericText_35

components_GenericText_36

components_GenericText_37

components_GenericText_38

components_GenericText_39

components_GenericText_40

components_GenericText_41

components_GenericText_42

components_GenericText_43

components_GenericText_44

components_GenericText_45

components_GenericText_46

components_GenericText_47

components_GenericText_48

components_GenericText_49

components_GenericText_50

components_GenericText_51

components_GenericText_52

components_GenericText_53

components_GenericText_54

components_GenericText_55

components_GenericText_56

components_GenericText_57

components_GenericText_58

components_GenericText_59

components_GenericText_60

components_GenericText_61

components_GenericText_62

components_GenericText_63

components_GenericText_64

components_GenericText_65

components_GenericText_66

components_GenericText_67

components_GenericText_68

components_GenericText_69

components_GenericText_70

components_GenericText_71

components_GenericText_72

components_GenericText_73

components_GenericText_74

components_GenericText_75

components_GenericText_76

components_GenericText_77

components_GenericText_78

components_GenericText_79

components_GenericText_80

components_GenericText_81

components_GenericText_82

components_GenericText_83

components_GenericText_84

components_GenericText_85

components_GenericText_86

components_GenericText_87

components_GenericText_88

components_GenericText_89

components_GenericText_90

components_GenericText_91

components_GenericText_92

components_GenericText_93

components_GenericText_94

components_GenericText_95

components_GenericText_96

components_GenericText_97

components_GenericText_98

components_GenericText_99

components_GenericText_100

components_GenericText_101

components_GenericText_102

components_GenericText_103

components_GenericText_104

components_GenericText_105

components_GenericText_106

components_GenericText_107

components_GenericText_108

components_GenericText_109

components_GenericText_110

components_GenericText_111

components_GenericText_112

components_GenericText_113

components_GenericText_114

components_GenericText_115

components_GenericText_116

components_GenericText_117

components_GenericText_118

components_GenericText_119

components_GenericText_120

components_GenericText_121

components_GenericText_122

components_GenericText_123

components_GenericText_124

components_GenericText_125

components_GenericText_126

components_GenericText_127

components_GenericText_128

components_GenericText_129

components_GenericText_130

components_GenericText_131

components_GenericText_132

components_GenericText_133

components_GenericText_134

components_GenericText_135

components_GenericText_136

components_GenericText_137

  • components_GenericText_138components_GenericText_139
  • components_GenericText_140components_GenericText_141
  • components_GenericText_142components_GenericText_143
  • components_GenericText_144components_GenericText_145
  • components_GenericText_146components_GenericText_147
  • components_GenericText_148components_GenericText_149
  • components_GenericText_150components_GenericText_151
  • components_GenericText_152components_GenericText_153
  • components_GenericText_154components_GenericText_155

components_GenericText_156

components_GenericText_157

components_GenericText_158

components_GenericText_159

components_GenericText_160

components_GenericText_161

components_GenericText_162

components_GenericText_163

  • components_GenericText_164components_GenericText_165
  • components_GenericText_166components_GenericText_167
  • components_GenericText_168components_GenericText_169
  • components_GenericText_170components_GenericText_171
  • components_GenericText_172components_GenericText_173
  • components_GenericText_174components_GenericText_175

components_GenericText_176

components_GenericText_177

components_GenericText_178

components_GenericText_179

components_GenericText_180

components_GenericText_181

components_GenericText_182

components_GenericText_183

components_GenericText_184

components_GenericText_185

components_GenericText_186

components_GenericText_187

components_GenericText_188

components_GenericText_189

components_GenericText_190

components_GenericText_191

components_GenericText_192

components_GenericText_193

components_GenericText_194

components_GenericText_195

components_GenericText_196

components_GenericText_197

components_GenericText_198

components_GenericText_199

components_GenericText_200

components_GenericText_201

components_GenericText_202

components_GenericText_203

components_GenericText_205components_GenericText_204

components_GenericText_207components_GenericText_206

components_GenericText_208components_GenericText_209

components_GenericText_210

components_GenericText_211components_GenericText_212

components_GenericText_213components_GenericText_214

components_GenericText_215components_GenericText_216

components_GenericText_217

components_GenericText_219components_GenericText_218

components_GenericText_220components_GenericText_221

components_GenericText_222components_GenericText_223

components_GenericText_224

components_GenericText_225

components_GenericText_226

components_GenericText_227

components_GenericText_228

components_GenericText_229

components_GenericText_230

components_GenericText_231

components_GenericText_232

components_GenericText_233

components_GenericText_234

components_GenericText_235

components_GenericText_236

components_GenericText_237

components_GenericText_238

components_GenericText_239

components_GenericText_240

components_GenericText_241

components_GenericText_242

components_GenericText_243

components_GenericText_244

components_GenericText_245

components_GenericText_246

components_GenericText_247

components_GenericText_248

components_GenericText_249

components_GenericText_250

components_GenericText_251

components_GenericText_252

components_GenericText_253

components_GenericText_254

components_GenericText_255

components_GenericText_256

components_GenericText_257

components_GenericText_258

components_GenericText_259

components_GenericText_260

components_GenericText_261

components_GenericText_262

components_GenericText_263

components_GenericText_264

components_GenericText_265

components_GenericText_266

components_GenericText_267

components_GenericText_268

components_GenericText_269

components_GenericText_270

components_GenericText_271

components_GenericText_272

components_GenericText_273 components_GenericText_274:

  • components_GenericText_275components_GenericText_276
  • components_GenericText_277components_GenericText_278
  • components_GenericText_279components_GenericText_280
  • components_GenericText_281components_GenericText_282
  • components_GenericText_283components_GenericText_284
  • components_GenericText_285components_GenericText_286
  • components_GenericText_287components_GenericText_288

components_GenericText_289

components_GenericText_290 components_GenericText_291:

  • components_GenericText_292components_GenericText_293
  • components_GenericText_294components_GenericText_295
  • components_GenericText_296components_GenericText_297
  • components_GenericText_298components_GenericText_299

components_GenericText_300

components_GenericText_301